Bioptimus: Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme
recent articles
[SEOUL, South Korea, Jul. 21, 2022] Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker “A32813”. Lunit’s initial public offering of...
Sectra: Cooper University Health Care in the US selects Sectra’s subscription model for enterprise imaging Linköping, Sweden – July 26, 2022 – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will...
Deep Bio: This designation marks the Korean government’s recognition of innovation for DeepDx®-Prostate Pro SEOUL, SOUTH KOREA (PRWEB) JULY 25, 2022 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics software,...
The Diagnexia Histopathology Symposium Wadham College, Oxford We are hosting a diagnostic pathology symposium in Wadham College, Oxford over the weekend of August 19-21, 2022. REGISTER NOW We have a stellar lineup of international...
(PresseBox) (Hamburg, 20.07.2022) Mindpeak announces the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest) supports pathologists in the scoring of digital images of breast cancer tissue, which underwent...
Rapid Deployment of Whole Slide Imaging for Primary Diagnosis in Surgical Pathology at Stanford Medicine: Responding to Challenges of the COVID-19 Pandemic Rebecca Rojansky, MD, PhD; Iny Jhun, MD, PhD; Alex M. Dussaq, MD, PhD; Steven...
